|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Dermatomyositis | |||||
| Glycogen Storage Disease Type II | |||||
| Glycogen Storage Disease Type VII | |||||
| Myositis | |||||
| Polymyositis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Glycogen Storage Disease | |||||
| Muscular Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Brain Diseases, Metabolic | |||||
| Brain Diseases, Metabolic, Inborn | |||||
| Carbohydrate Metabolism, Inborn Errors | |||||
| Central Nervous System Diseases | |||||
| Connective Tissue Diseases | |||||
| Genetic Diseases, Inborn | |||||
| Lysosomal Storage Diseases | |||||
| Lysosomal Storage Diseases, Nervous System | |||||
| Metabolic Diseases | |||||
| Metabolism, Inborn Errors | |||||
| Muscular Disorders, Atrophic | |||||
| Muscular Dystrophies | |||||
| Musculoskeletal Diseases | |||||
| Nervous System Diseases | |||||
| Neuromuscular Diseases | |||||
| Skin Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | |||||